Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Reactogenicity of GSK's dTpa-IPV Vaccine
NCT01277705Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2002
- Primary completion
- Apr 2002
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of Boostrix Polio in Tetanus, diphtheria, pertussis, poliomyelitis, sponsored by GSK. Started Jan 2002; status: completed.
02
Drugs
Boostrix Polio
03
Conditions
Tetanusdiphtheriapertussispoliomyelitis
Beyond the preview
Go deeper on NCT01277705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01277705.